Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Institute for Clinical Immuno-Oncology

Advertisement

Articles by Institute for Clinical Immuno-Oncology

Institute for Clinical Immuno-Oncology (ICLIO) Delivers Immunotherapy Education in the Community Setting

ByInstitute for Clinical Immuno-Oncology
June 22nd 2017

The Insitute for Clinical Immuno-Oncology (ICLIO) are supporting multidisciplinary cancer teams to better deliver new and emerging cancer therapies.

Advertisement

Latest Updated Articles

  • Institute for Clinical Immuno-Oncology (ICLIO) Delivers Immunotherapy Education in the Community Setting
    Institute for Clinical Immuno-Oncology (ICLIO) Delivers Immunotherapy Education in the Community Setting

    June 22nd 2017



Advertisement
Advertisement

Trending on Oncology Nursing News

1

GLP-1s in Oncology: Nurses Face Paradox in Symptom Management

2

GLP-1 Use Linked to 30% Reduced Breast Cancer Risk in Large Cohort Study

3

ROSELLA: Relacorilant Combination Delays Progression, Extends Survival

4

Nursing Insights: ASCENT-04 Results and Toxicity Management From ASCO

5

GLP-1 RAs Linked to Lower HR+ Breast Cancer Risk and Improved Survival

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us